Kate brings to Corvia Medical more than 15 years of experience successfully developing and executing regulatory, clinical and quality control strategies for new interventional cardiology devices. Most recently Kate co-founded and held the position of Vice President Regulatory and Clinical Affairs for MitraSpan, a minimally invasive mitral valve repair technology.

Prior to MitraSpan, Kate was the COO for Thermedical, developing a ventricular tachycardia treatment, and VP Clinical and Regulatory Affairs for Viacor, treating mitral regurgitation percutaneously. Previously Kate held factory and global management positions with Hewlett-Packard Company Medical Products and Agilent Technologies with functional responsibilities in manufacturing, product development, and engineering, and a clinical focus on cardiac ultrasound imaging. Kate holds a BS Materials Science from Massachusetts Institute of Technology and MBA from Harvard Business School.

• 

  Vice President, Quality Assurance & Regulatory Affairs in Corvia

  Transforming the Treatment of Heart Failure